Zobrazeno 1 - 10
of 18
pro vyhledávání: '"R. E. Faught"'
Autor:
Thomas R. Browne, A. Beydoun, Mark Nespeca, William H. Theodore, Deborah Hirtz, Blaise F. D. Bourgeois, James H. Fischer, Georgia Montouris, John M. Stern, William R. Turk, Steven C. Schachter, Andrew Wilner, Jocelyn F. Bautista, R. E. Faught, Carl W. Bazil, William J. Marks, Jacqueline A. French, Barry E. Gidal, Donna Bergen, Bassel Abou-Khalil, Cynthia L. Harden, Rajesh C. Sachdeo, Andres M. Kanner, Tracy A. Glauser
Publikováno v:
CONTINUUM: Lifelong Learning in Neurology. 13:203-211
Autor:
J. A. French, A. M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C. L. Harden, W. H. Theodore, C. Bazil, J. Stern, S. C. Schachter, D. Bergen, D. Hirtz, G. D. Montouris, M. Nespeca, B. Gidal, W. J. Marks, W. R. Turk, J. H. Fischer, B. Bourgeois, A. Wilner, R. E. Faught, R. C. Sachdeo, A. Beydoun, T. A. Glauser
Publikováno v:
Neurology. 62:1261-1273
Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide) in the treatment of children and
Autor:
Ahmad Beydoun, James H. Fischer, Thomas R. Browne, R. E. Faught, William H. Theodore, Cynthia L. Harden, Georgia Montouris, Jacqueline A. French, Andrew Wilner, Deborah Hirtz, R. Sachdeo, John M. Stern, Carl W. Bazil, Steven C. Schachter, Mark Nespeca, William R. Turk, Tracy A. Glauser, Andres M. Kanner, Donna Bergen, Blaise F. D. Bourgeois, William J. Marks, Bassel Abou-Khalil, Barry E. Gidal, Jocelyn F. Bautista
Publikováno v:
Scopus-Elsevier
Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide—reviewed in the order in which
Autor:
R E. Faught, L Magnus-Miller, A Rose-Legatt, Gregory L. Holmes, Michael J. McLean, Martha J. Morrell, P Bernstein, L. J. Willmore, Michael Privitera
Publikováno v:
Epilepsia. 40:965-972
Summary: Purpose: To evaluate the tolerability and safety of gabapentin (GBP) as add-on therapy for seizure control. Methods: Conducted in an outpatient setting and reflecting usual practice, this study compared tolerability of GBP dosages ≤1,800 v
Publikováno v:
Neurology. 75(22)
Autor:
Ruben Kuzniecky, S. Sawrie, Frank Gilliam, Roy C. Martin, James W. Hugg, R. E. Faught, M. Viikinsalo, B. Maton
Publikováno v:
Neurology. 68(5)
Objective: To investigate the association of an indicator of hippocampal function with severity of depression symptoms in temporal lobe epilepsy. Methods: We evaluated 31 patients with video/EEG-confirmed temporal lobe epilepsy using creatine/N-acety
Publikováno v:
Epilepsia. 38:S34-S36
Because initial studies of new antiepileptic drugs (AEDs) are add-on trials in refractory patient populations, their effectiveness as monotherapy is usually not apparent until relatively later in their development programs. The novel AED topiramate (
Autor:
A. Prasad, R. I. Kuzniecky, R. C. Knowlton, T. E. Welty, R. C. Martin, M. Mendez, R. E. Faught
Publikováno v:
Archives of Neurology. 61
Autor:
J. Torgovnick, N. Sethi, E. Arsura, J. B. Martin, S. R. Benbadis, R. E. Faught, J. Sirven, J. D. Slater, M. R. Sperling, L. J. Hirsch
Publikováno v:
Neurology. 75:2045-2046
Autor:
M J, Morrell, M J, McLean, L J, Willmore, M D, Privitera, R E, Faught, G L, Holmes, L, Magnus, P, Bernstein, Rose-Legatt
Publikováno v:
Seizure. 9(4)
The objective of this study was to determine the efficacy of gabapentin as adjunctive therapy in doses required to achieve the most effective seizure control. There were 2016 patients with partial seizures requiring adjunctive therapy who received ga